Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-04-01
|
| Series: | Revista Portuguesa de Cardiologia |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0870255123004602 |
| _version_ | 1827304359145242624 |
|---|---|
| author | Jorge Gonçalves Catarina D. Santos Paula Fresco Fernando Fernandez-Llimos |
| author_facet | Jorge Gonçalves Catarina D. Santos Paula Fresco Fernando Fernandez-Llimos |
| author_sort | Jorge Gonçalves |
| collection | DOAJ |
| first_indexed | 2024-04-24T17:29:44Z |
| format | Article |
| id | doaj.art-c6bf5cdaf8a24c4b8db5c246556e2f7c |
| institution | Directory Open Access Journal |
| issn | 0870-2551 |
| language | English |
| last_indexed | 2024-04-24T17:29:44Z |
| publishDate | 2024-04-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Revista Portuguesa de Cardiologia |
| spelling | doaj.art-c6bf5cdaf8a24c4b8db5c246556e2f7c2024-03-28T06:36:56ZengElsevierRevista Portuguesa de Cardiologia0870-25512024-04-01434221222Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the oneJorge Gonçalves0Catarina D. Santos1Paula Fresco2Fernando Fernandez-Llimos3Laboratório de Farmacologia, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal; Mechanistic Pharmacology and Pharmacotherapy Unit, UCIBIO-i4HB, Faculty of Pharmacy, University of Porto, Porto, Portugal; Corresponding author.Laboratório de Farmacologia, Faculdade de Farmácia, Universidade do Porto, Porto, PortugalLaboratório de Farmacologia, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal; Mechanistic Pharmacology and Pharmacotherapy Unit, UCIBIO-i4HB, Faculty of Pharmacy, University of Porto, Porto, PortugalLaboratório de Farmacologia, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal; Mechanistic Pharmacology and Pharmacotherapy Unit, UCIBIO-i4HB, Faculty of Pharmacy, University of Porto, Porto, Portugalhttp://www.sciencedirect.com/science/article/pii/S0870255123004602 |
| spellingShingle | Jorge Gonçalves Catarina D. Santos Paula Fresco Fernando Fernandez-Llimos Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one Revista Portuguesa de Cardiologia |
| title | Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one |
| title_full | Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one |
| title_fullStr | Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one |
| title_full_unstemmed | Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one |
| title_short | Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one |
| title_sort | reply to raas inhibitors in covid 19 not all are created equal telmisartan is the one |
| url | http://www.sciencedirect.com/science/article/pii/S0870255123004602 |
| work_keys_str_mv | AT jorgegoncalves replytoraasinhibitorsincovid19notallarecreatedequaltelmisartanistheone AT catarinadsantos replytoraasinhibitorsincovid19notallarecreatedequaltelmisartanistheone AT paulafresco replytoraasinhibitorsincovid19notallarecreatedequaltelmisartanistheone AT fernandofernandezllimos replytoraasinhibitorsincovid19notallarecreatedequaltelmisartanistheone |